Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Ruiying Pharmaceutical is a comprehensive pharmaceutical enterprise headquartered in Haikou, Hainan Province, China. Established in 2003, the company specializes in the research, development, manufacturing, and marketing of chemical drugs, with a primary focus on anti-infective agents. Its extensive product portfolio includes widely used antibiotics such as Cefixime and Azithromycin, alongside treatments for cardiovascular and gastrointestinal conditions. The company operates modern, GMP-certified manufacturing facilities capable of producing various dosage forms, including oral solids and sterile injectables. Recognized as a National High-tech Enterprise, Ruiying plays a significant role in the pharmaceutical industrial cluster of the Hainan Free Trade Port.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Ruiying Technology.